Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
LHGDN |
[Molecular pathogenesis of fragile X syndrome].
|
12810982 |
2003 |
Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
X chromosome microarray revealed a large deletion encompassing the genes IDS, FMR1, and AFF2 (FMR2) confirming the diagnoses of both Hunter and fragile X syndromes.
|
22190500 |
2012 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Women who develop primary ovarian insufficiency related to a premutation in FMR1 are at risk of having a child with fragile X syndrome, the most common cause of inherited intellectual disability.
|
27827529 |
2017 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Women who carry an FMR1 premutation (PM) allele and are mothers of children with fragile X syndrome (FXS) experience elevated maternal stress.
|
30959430 |
2019 |
Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Wnd/DLK Is a Critical Target of FMRP Responsible for Neurodevelopmental and Behavior Defects in the Drosophila Model of Fragile X Syndrome.
|
31484070 |
2019 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
With the cloning of the FMR-1 gene, direct mutation analysis is possible for fragile X syndrome.
|
7943028 |
1994 |
Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
While there is no definitive cure for FXS, the understanding of FMRP function has paved the way for rational treatment designs that could potentially reverse many of the neurobiological changes observed in FXS.
|
23202739 |
2012 |
Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
While alterations in excitatory synapse function and plasticity are well-established in Fmr1 knockout (KO) mouse models of FXS, a number of recent electrophysiological and molecular studies now identify prominent defects in inhibitory GABAergic transmission in behaviorally relevant forebrain regions such as the amygdala, cortex, and hippocampus.
|
21934270 |
2011 |
Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
While FMR1 is silenced in Fragile X syndrome (FXS) patients carrying the full mutation, its expression is elevated (2-8 fold) in premutated individuals.
|
23390134 |
2013 |
Fragile X Syndrome
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Whether fragile X mental retardation protein (FMRP) target mRNAs and neuronal activity contributing to elevated basal neuronal protein synthesis in fragile X syndrome (FXS) is unclear.
|
30979884 |
2019 |
Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Whereas FXS is caused by gene silencing and insufficient FMR1 protein (FMRP), FXTAS is thought to be caused by 'toxicity' of expanded-CGG-repeat mRNA.
|
24463622 |
2014 |
Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
We used a selective BKCa channel opener molecule (BMS-204352) to address this issue in Fmr1 KO mice, modeling the FXS pathophysiology.
|
25079250 |
2014 |
Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
We used a mouse model of FXS (Fmr1 KO) to study sensory processing of tactile information conveyed via the whisker system.
|
27616423 |
2016 |
Fragile X Syndrome
|
1.000 |
PosttranslationalModification
|
disease |
BEFREE |
We studied the methylation status of the CpG island of the FMR-1 (fragile X syndrome) gene to recognize the possibility of its prenatal diagnosis with early pregnant subjects.
|
7989507 |
1994 |
Fragile X Syndrome
|
1.000 |
PosttranslationalModification
|
disease |
BEFREE |
We show that a novel fragile X-related epigenetic element 2 FMR1 methylation test can be used along with a test for sex-determining region Y (SRY) to provide the option of combined fragile X syndrome and sex chromosome aneuploidy newborn screening.
|
23060046 |
2013 |
Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
We show here that in mouse models PFC dysfunction in Fragile X Syndrome (FX) can be attributed to the continued absence of FMRP from the PFC, independent of FMRP status during development.
|
28652410 |
2017 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We show here that an intrinsic problem with DNA replication exists in the FMR1 gene of individuals with FXS even in the absence of FdU.
|
24419320 |
2014 |
Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
We screened a cohort of patients with typical FXS symptoms who tested negative for CGG repeat expansion in the FMR1 locus.
|
25693964 |
2015 |
Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
We review here a set of targets of FMRP (mRNAs and proteins) that may have an impact on the FXS phenotype by deregulating some key cellular processes, such as translation, cytoskeleton remodeling and oxidative stress.
|
24462888 |
2014 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We report on the allele distributions in a normal black African population at two microsatellite loci neighbouring the FRAXA locus and at the CGG repeat in the 5' end of the FMR-1 gene, which causes the fragile X syndrome.
|
8826479 |
1996 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We report on the allele distribution in a normal Chilean population at 2 microsatellite loci neighbouring the FRAXA locus and at the CGG repeat in the 5' end of the FMR-1 gene, which causes the fragile X syndrome.
|
9475597 |
1998 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We report here the identification of two different intragenic loss of function mutations in FMR1: a single de novo nucleotide deletion in a young male patient (IJ) and an inherited two basepair change in an Adult male (SD), each with classical features of fragile X syndrome.
|
7670500 |
1995 |
Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
We report here the identification of two different intragenic loss of function mutations in FMR1: a single de novo nucleotide deletion in a young male patient (IJ) and an inherited two basepair change in an Adult male (SD), each with classical features of fragile X syndrome.
|
7670500 |
1995 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We report a postmortem study of the FMR1 mutation in multiple tissues from a high-functioning male with fragile X syndrome.
|
10331599 |
1999 |
Fragile X Syndrome
|
1.000 |
Biomarker
|
disease |
LHGDN |
We propose that the neurological defects in Fragile X syndrome, including the autistic features, could be due in part to the loss of FMRP function in presynaptic compartments.
|
19193898 |
2009 |